No IPOs on the calendar this week.
No IPOs are scheduled for the week of October 18, 2026. Over the past seven days, 3 started trading, 5 filed to go public, 2 postponed or withdrew.
Last week's debuts
| Symbol | Company | IPO price | Day-1 open | Day-1 close | Latest | vs IPO price |
|---|
| AMRO | Amaero Inc. | $7.06 | — | — | $4.50 | -36.3% |
| IAM | Iambic Therapeutics, Inc. | — | — | — | $23.81 | — |
| CTY | CITY THERAPEUTICS, INC. | $18.00 | — | — | $22.40 | +24.4% |
Lock-ups and quiet periods ending
Lock-up expiry frees insiders to sell. The quiet period's end lets the underwriters' analysts start coverage. A weekend date takes effect on the Monday. Returns account for splits.
| Symbol | Company | Event | Date | IPO price | Latest | vs IPO price |
|---|
| DETX | LIBERTY DEFENSE HOLDINGS, LTD. | Lock-up | Mon, Oct 19 | $4.50 | $1.44 | -68.0% |
| NHP | National Healthcare Properties, Inc. | Lock-up | Mon, Oct 19 | $12.00 | $15.11 | +25.9% |
| YSWY | Yesway, Inc. | Lock-up | Mon, Oct 19 | $20.00 | $23.15 | +15.7% |
| ELMT | Elmet Group Co. | Lock-up | Tue, Oct 20 | $14.00 | $18.93 | +35.2% |
| XE | X-Energy, Inc. | Lock-up | Wed, Oct 21 | $23.00 | $10.36 | -55.0% |
Postponed and withdrawn
| Date | Company | Symbol | Status |
|---|
| Wed, Oct 14 | BIOVENTRIX, INC. | — | Withdrawn |
| Sun, Oct 11 | CITY THERAPEUTICS, INC. | CTY | Postponed |
New filings
| Date | Company | Symbol | Filing |
|---|
| Fri, Oct 16 | AMAZE HOLDINGS, INC. | VINE | S-1 |
| Fri, Oct 16 | WhiteHawk Minerals Corp. | WHK | S-1 |
| Thu, Oct 15 | iPower Inc. | IPW | S-1 |
| Wed, Oct 14 | Green Circle Decarbonize Technology Ltd | GCDT | F-1 |
| Tue, Oct 13 | Arxis, Inc. | ARXS | S-1 |
Factor research — October 2026
3M look-ahead — IPOs priced in the last 12 months
| Variable | n | IC | p | Q5−Q1 spread | Robust |
|---|
| Stock-based comp / revenue % | 20 | -0.609 | 0.003 | -67.107 | ✓ |
| Interest coverage (EBIT / interest) | 30 | 0.598 | <0.001 | 123.683 | ✓ |
| Direct listing (0/1) | 128 | -0.465 | <0.001 | -64.843 | ✓ |
| SG&A / revenue % | 35 | -0.424 | 0.024 | -48.274 | |
| EBITDA margin % | 73 | 0.397 | 0.006 | 72.706 | ✓ |
| Op. cash flow / revenue % | 45 | 0.376 | 0.034 | 43.082 | |
| Direct listing < $1000M cap (0/1) | 127 | -0.376 | <0.001 | -50.013 | ✓ |
| Operating margin % | 73 | 0.372 | 0.006 | 71.282 | ✓ |
Multivariate (3M):
Cross-validated Elastic Net (n=127, α=14.40, CV R²=0.008), standardized coefficients:
| Variable | Coefficient |
|---|
| Direct listing (0/1) | -1.9326 |
| Direct listing < $1000M cap (0/1) | -1.4172 |
| Net margin % | 1.0430 |
| Deal-structure flag (0-1) | 0.8301 |
| Return on assets % | 0.7678 |
| Quick ratio | 0.5814 |
6M look-ahead — IPOs priced in the last 12 months
| Variable | n | IC | p | Q5−Q1 spread | Robust |
|---|
| Interest coverage (EBIT / interest) | 28 | 0.649 | <0.001 | 384.470 | ✓ |
| Beneish M-score (manipulation) | 24 | 0.510 | 0.058 | 313.112 | |
| SG&A growth % (YoY) | 27 | 0.462 | 0.132 | 271.103 | |
| Cash runway (months) | 35 | 0.425 | 0.078 | 205.108 | |
| Op. cash flow / revenue % | 42 | 0.393 | 0.045 | 132.594 | |
| Free cash flow / revenue % | 42 | 0.369 | 0.102 | 132.594 | |
| UW syndicate: mid-market / quality bank (0/1) | 71 | 0.360 | 0.006 | 143.466 | |
| Operating cash flow yield % | 57 | 0.355 | 0.029 | 154.203 | |
Multivariate (6M):
Elastic Net shrank every coefficient to zero.
